Tmunity Therapeutics, Inc, based in Philadelphia, is at the forefront of developing innovative T cell therapies. Their focus includes T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms.
With a commitment to advancing Chimeric Antigen Receptor (CAR) T cell therapies, Tmunity Therapeutics is dedicated to revolutionizing the field of immunotherapy through cutting-edge research and development.
Generated from their website's infomation